Clinical Trial Update: ABT-751 With Chemotherapy for Relapsed Pediatric ALL [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 trial of ABT-751 combined with chemotherapy for relapsed/recurrent pediatric acute lymphoblastic leukemia was terminated with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• ABT-751 (ABT-751)

Snippet

Sponsor: Therapeutic Advances in Childhood Leukemia Consortium | Conditions: Recurrent Pediatric ALL, Relapsed Pediatric ALL | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2020-09-09